表皮状肉瘤的预后决定因素和生存结果:对1123名患者的当代基于人口的分析
1College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Medicine
|February 24, 2026
概括
表皮状肉瘤生存率受到远程阶段,区域阶段,瘤大小和患者年龄的影响. 手术切除为患有表皮性肉瘤的患者提供了显著的生存益处.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 流行病学 流行病学
背景情况:
- 表皮状肉瘤是一种罕见的,侵袭性的软组织癌症.
- SMARCB1/INI1基因失活是表皮性肉瘤的一个标志.
- 有限的基于人口的数据存在于表皮性肉瘤的预后因素.
研究的目的:
- 为了评估表皮性肉瘤患者的生存结果.
- 确定影响生存的独立预后因素.
- 分析来自大量基于人口的队列的数据.
主要方法:
- 从SEER 17注册表数据库 (2001-2022) 中对1123名上皮类肉瘤患者的回顾性分析.
- 使用考克斯的比例危险回归来确定预后因素.
- 用Kaplan-Meier分析和日志级别测试进行生存比较.
主要成果:
- 癌症特定的5年生存率为53.7%.
- 不利的预后因素包括远程阶段,区域阶段,增加瘤大小和年龄.
- 手术切除与显著的生存益处相关 (aHR=0.397).
结论:
- 诊断阶段是表皮性肉瘤预后的主要决定因素.
- 手术切除在所有疾病阶段都提供了一致的生存优势.
- 改善的生存率可能归因于诊断和多模式治疗的进步.
相关概念视频
Cancer Survival Analysis
796
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
796
Kaplan-Meier Approach
657
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
657


